All Practice-based pharmacist articles
-
InformationKey COVID-19 guidance for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of ...
-
PHE/DH/DWP guideline
PHE influenza immunisation guideline
This Guidelines summary covers key points for administering influenza immunisation, and who should receive it.
-
PHE/DH/DWP guideline
PHE guideline on management of exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
Independent professional body guideline
FSRH UKMEC contraception guideline
A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.
-
Independent professional body guideline
ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
-
Independent professional body guideline
PCDS management of acne guideline
A concise summary of the Primary Care Dermatology Society's guideline on the treatment of acne vulgaris.
-
Independent professional body guideline
PCDS atopic eczema guideline
An overview of the management of atopic eczema. Covers taking a clinical history, step-by-step treatment, and includes an eczema management plan.
-
PHE/DH/DWP guideline
PHE pneumococcal vaccination guideline (Green Book chapter 25)
A succinct summary of Public Health England’s Green Book chapter 25 pneumococcal vaccination programme
-
Independent professional body guideline
Recognition and management of sepsis in general practice
This Guidelines summary combines recommendations from The UK Sepsis Trust to give guidance on the recognition and management of sepsis in adults, children, and young people over 12 years of age
-
NHS guideline
NHS England COVID-19 community pharmacy guideline
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. This guidance is correct at the time of publishing. The Guidelines team review the information daily and update as ...
-
Independent professional body guideline
Recommended actions after incorrect use of combined hormonal contraception
This Guidelines summary guides management for when a woman has made a mistake using combined oral contraceptive pills, combined vaginal ring, and combined transdermal patch.
-
NICE guideline
NICE CKS—teething
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
-
Independent professional body guideline
Consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update
This summary covers key recommendations for diagnosis and treatment of insomnia, parasomnia, and circadian rhythm disorders relevant to primary care.
-
NICE guideline
NICE sepsis guideline
This Guidelines summary covers recognition, diagnosis, and early management of sepsis for all populations. It should be used together with NICE's algorithms organised by age group and treatment location and the risk stratification tools. Please refer to the full guideline for a complete list of recommendations.
-
Independent professional body guideline
SPS advice to chief pharmacists: assessing the quality of cannabis-based products for medicinal use (CBPM) and cannabis-based food supplements available in the UK
Summary This document provides an overview of the quality assurance issues to consider when procuring and supplying cannabis products for medicinal use. 1. With the exception of Sativex, cannabis-based products available in the UK fall into 3 categories: Unlicensed cannabis-based products for medicinal ...
-
Independent professional body guideline
PCDS actinic keratosis guideline
This Guidelines summary includes recommendations on recognition and diagnosis of actinic keratosis, use of clinical findings, management and options for treatment. It includes an algorithm of the pathway from recognition to treatment in primary care, including red flags to recognise.
-
NICE guideline
NICE CKS candida—female genital
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting.
-
NICE guideline
NICE CKS—cow’s milk allergy in children
What is it? Food allergy describes an adverse immune-mediated response, which occurs when a person is exposed to specific food allergen(s), usually by ingestion and more rarely by inhalation or skin contact Cow’s milk allergy is a reproducible immune-mediated allergic response to one ...
-
NICE guideline
NICE impetigo guideline
Overview This guideline sets out an antimicrobial prescribing strategy for adults, young people, and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance. For further information, please view the full guideline. ...
-
NICE guideline
NICE CKS—diarrhoea
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. For community pharmacists, the referral section implies primary care referral prior to secondary care referral. Please see the full guideline ...
